What is belimumab?
Belimumab (brand name Benlysta) is a biologic medication used to treat systemic lupus erythematosus (SLE) and lupus nephritis — lupus that affects the kidneys. It was the first biologic ever approved specifically for lupus, and it is added to your standard lupus therapy rather than replacing it.
Belimumab is a BLyS inhibitor. BLyS (B-lymphocyte stimulator, also called BAFF) is a protein that helps a type of immune cell — the B cell — survive. In lupus, overactive B cells produce the autoantibodies that attack your own tissues. By binding and neutralizing BLyS, belimumab reduces the survival of these B cells, which lowers autoantibody production and calms lupus activity over time.
How to take it
Belimumab comes in two forms, and both deliver the same medication.
Subcutaneous injection (at home):
- Given as a once-weekly injection under the skin using a prefilled autoinjector pen or syringe.
- For SLE: 200 mg once weekly.
- For lupus nephritis: 400 mg once weekly (two 200 mg injections) for the first 4 weeks, then 200 mg once weekly after that.
- Self-administered at home after training in our office.
- Store in the refrigerator — remove and let it reach room temperature for about 30 minutes before injecting. Do not warm it any other way and do not shake it.
- Rotate injection sites between the thigh and abdomen. When two injections are needed, give them at least 2 inches apart.
Intravenous infusion (in-office):
- 10 mg/kg based on your weight, given as a 1-hour IV infusion at our on-site infusion center.
- The first three infusions are given at weeks 0, 2, and 4, then every 4 weeks thereafter.
- Given by our nursing staff — you can read, work, or relax during the session.
The at-home injection is for adults. Children are treated with the IV infusion form. Your rheumatologist will recommend which route fits your diagnosis, age, insurance, and preference.
What to expect when starting
Belimumab works gradually. Most patients begin to notice benefit around 3 to 4 months, with a fuller, more durable response by about 6 months. It is not a rescue drug for a sudden flare — it works by slowly reducing the immune activity that drives lupus.
Because the benefit builds slowly, keep taking your other lupus medications exactly as prescribed while belimumab takes effect. Over time, controlling your lupus with belimumab may let us reduce your steroid dose.
Lab monitoring
- Baseline blood work before starting — CBC, metabolic panel, and infection screening.
- Periodic blood work while on therapy to monitor your blood counts and overall health.
- We also track your lupus markers (such as complement levels and anti-dsDNA antibodies) to measure how well the medication is working.
Side effects to watch for
Common:
- Nausea and diarrhea — usually mild.
- Fever, sore throat, or cold symptoms (nasopharyngitis, bronchitis).
- Trouble sleeping and headache or migraine.
- Injection site reactions (SC form) or infusion reactions (IV form) — redness, irritation, or mild discomfort.
Important — contact us if you experience:
- New or worsening depression, anxiety, mood changes, or thoughts of harming yourself. Belimumab has been linked to serious mood changes and suicidal thoughts in some patients — this is important and treatable, so tell us or a loved one right away.
- Fever, chills, or any signs of infection — persistent cough, burning with urination, or a wound that isn’t healing.
- Signs of an allergic reaction — hives, swelling of the face or throat, trouble breathing, or a rash. These reactions can be delayed, sometimes hours after a dose or even after several doses you tolerated before.
- New confusion, weakness on one side, vision changes, or difficulty speaking — very rare but important signs of a serious brain infection (PML).
Important: Because belimumab can affect mood, tell us — or ask a family member to tell us — about any new or worsening depression, mood changes, or thoughts of self-harm. Don’t wait for your next appointment.
Required screening before starting
As with any medication that affects the immune system, before your first dose we will:
- Screen for tuberculosis and hepatitis — standard safety checks before starting a biologic.
- Check baseline blood work — CBC and metabolic panel.
- Review your vaccination history — certain vaccines should be given before starting.
- Assess your mood and mental health history — so we can monitor appropriately during treatment.
Things to avoid
- Live vaccines — do not receive a live vaccine within 30 days before starting belimumab or while taking it. Inactivated vaccines (flu shot, COVID, Shingrix) are safe — try to get them up to date before starting, since belimumab may blunt your response to vaccines.
- Other biologics — belimumab should not be combined with another biologic. Doing so raises infection risk without added benefit.
- Don’t ignore infections — if you develop signs of infection, contact us. We may hold a dose until it clears.
IV infusion vs. at-home injection
Both forms are equally effective — the choice is about what fits your life:
- IV infusion — every 4 weeks at our on-site infusion center, no self-injection needed. A good option if you prefer supervised care or don’t want to inject at home.
- At-home injection — weekly, on your own schedule, no office visit needed for each dose. Most patients find the autoinjector easy after initial training.
Many patients switch between forms over time. Either transition is straightforward.
Frequently asked questions
Will belimumab cure my lupus? No — belimumab controls lupus, it doesn’t cure it. When it works well, it reduces flares, calms disease activity, and often allows a lower steroid dose. Most patients stay on it long-term as long as it keeps helping.
Why does the kidney (lupus nephritis) dose start higher? Lupus nephritis needs a stronger initial push, so the at-home injection uses a higher loading dose — 400 mg weekly for the first 4 weeks — before settling to the usual 200 mg weekly. The IV dose is the same 10 mg/kg for both conditions.
What if I miss a dose? For at-home injections: take it as soon as you remember, then resume your weekly schedule. For IV infusions: call us to reschedule as soon as possible, ideally within a week of your scheduled date.
Can I take belimumab during pregnancy? This is an individual decision. Belimumab crosses the placenta, especially later in pregnancy, so we weigh it against how active your lupus is. Tell us early if you’re pregnant or planning to be. There is a Benlysta pregnancy registry you can enroll in — we can help you sign up.
This handout is provided for educational purposes and does not replace individualized medical advice. Always follow the specific instructions given by your rheumatologist.